Compounds as GCN2 inhibitors, pharmaceutical compositions and uses thereof
US12240836B2 · kind B2 · utility
0Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 5, 2022 |
| Grant date | Mar 4, 2025 |
| Priority date | — |
| Expiry date | Sep 1, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are novel compounds, e.g., those of Formula (I), as GCN2 inhibitors. Also provided are pharmaceutical compositions including one or more of the novel compounds, and pharmaceutical uses thereof. Compounds provided herein can typically inhibit an activity of a GCN2 and thus can be used for treating or preventing diseases related thereto.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.